Homepage zuehlke.com
Zühlke and University of St.Gallen partner to drive operational excellence in pharma
Pharmaceutical manufacturing is at a critical inflection point. As drug development accelerates, production systems are struggling to keep pace. Companies face complex challenges – from labour-intensive quality control processes and inflexible production lines to regulatory hurdles and vulnerable supply chains. These issues don’t just slow operations; they risk delaying patient access to life-saving therapies.
HSG’s renowned operational excellence benchmarking, built over two decades, has been supporting the industry in tackling these challenges. Their database includes insights from more than 450 manufacturing sites worldwide, spanning 140+ companies – including 18 of the world’s top 20 pharmaceutical firms by revenue.
“This partnership underlines Zühlke’s strategic commitment to the pharmaceutical and health sectors. Together, we will tailor digitalisation and automation solutions to address real-world performance gaps and empower our clients to deliver on their mission to patients.”
By combining these insights with Zühlke’s expertise in digital transformation and AI-powered solutions, the partnership aims to help pharma companies enhance product quality, ensure regulatory compliance, reduce costs, and accelerate time-to-market – ultimately improving patient outcomes.
“Partnering with Zühlke allows us to translate our operational excellence insights into actionable, technology-driven improvements for pharmaceutical manufacturing. With this partnership, we’re enabling pharma companies to achieve sustainable transformation in their operations.”
